Predictors of 30-day mortality and outcome in cases of myocardial infarction with cardiogenic shock treated by extracorporeal life support

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 1, 2014, Pages 47-54

  Demondion, Pierre ^a   Fournel, Ludovic ^a   Golmard, Jean Louis ^a   Niculescu, Michaela ^a   Pavie, Alain ^a   Leprince, Pascal ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Acute myocardial infarction; Cardiogenic shock; Extracorporeal life support

Indexed keywords

ADRENALIN; ASPARTATE AMINOTRANSFERASE; CREATININE; DOBUTAMINE; HYPERTENSIVE AGENT; INOTROPIC AGENT; LACTIC ACID; TROPONIN I; VASOACTIVE AGENT;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIVENTRICULAR ASSIST DEVICE; BLEEDING; CARDIAC PATIENT; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DOPPLER ECHOCARDIOGRAPHY; DRUG DOSE REDUCTION; EMERGENCY CARE; EXTRACORPOREAL LIFE SUPPORT; EXTRACORPOREAL OXYGENATION; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HEART VENTRICLE SEPTUM RUPTURE; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LIMB ISCHEMIA; LOW DRUG DOSE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; MEDICAL RECORD REVIEW; MIDDLE AGED; MITRAL VALVE REPLACEMENT; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROTHROMBIN TIME; REPEAT PROCEDURE; RESUSCITATION; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; TREATMENT DURATION; WOUND INFECTION;

ACUTE MYOCARDIAL INFARCTION; CARDIOGENIC SHOCK; EXTRACORPOREAL LIFE SUPPORT;

CORONARY ARTERY BYPASS; EXTRACORPOREAL CIRCULATION; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVAL ANALYSIS;

EID: 84890513545     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt207     Document Type: Article

References (25)

1. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162-8.
2. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD et al. SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med 1999;341:625-34.
3. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA et al. Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK trial registry. J Am Coll Cardiol 2000;36:1063-70.
4. Chen YS, Chao A, Yu HY, Ko WJ, Wu IH, Chen RJ et al. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. J Am Coll Cardiol 2003;41: 197-203.
5. Mégarbane B, Leprince P, Deye N, Résière D, Guerrier G, Rettab S et al. Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intensive Care Med 2007;33:758-64.
6. Chen JS, Ko WJ, Yu HY, Lai LP, Huang SC, Chi NH et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med 2006;34:950-7.
7. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001;141:933-9.
8. Sjauw KD, Engström AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009;30:459-68.
9. Yip HK, Wu CJ, Chang HW, Chen MC, Hang CL, Fang CY et al. Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am J Cardiol 2001;87:1184-8; A1184.
10. Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with inhospital cardiac arrest: An observational study and propensity analysis. Lancet 2008;372:554-61.
11. Kim H, Lim SH, Hong J, Hong YS, Lee CJ, Jung JH et al. Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. Resuscitation 2012;83:971-5.
12. Formica F, Avalli L, Colagrande L, Ferro O, Greco G, Maggioni E et al. Extracorporeal membrane oxygenation to support adult patients with cardiac failure: predictive factors of 30-day mortality. Interact Cardiovasc Thorac Surg 2010;10:721-6.
13. Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002;73:538-45.
14. Bakhtiary F, Keller H, Dogan S, Dzemali O, Oezaslan F, Meininger D et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 2008;135:382-8.
15. Kirsch M, Boval B, Damy T, Ghendouz S, Vermes E, Loisance D et al. Importance of monocyte deactivation in determining early outcome after ventricular assist device implantation. Int J Artif Organs 2012;35: 169-76.
16. Johnson D, Mayers I. Multiple organ dysfunction syndromes: a narrative review. Can J Anaesth 2001;48:502-9.
17. Hummel M, Czerlinski S, Friedel N, Liebenthal C, Hasper D, von Baehr R et al. Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation. Crit Care Med 1994;22:448-54.
18. Sakamoto S, Taniguchi N, Nakajima S, Takahashi A. Extracorporeal life support for cardiogenic shock or cardiac arrest due to acute coronary syndrome. Ann Thorac Surg 2012;94:1-7.
19. Aissaoui N, Luyt CE, Leprince P, Trouillet JL, Léger P, Pavie A et al. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med 2011;37:1738-45.
20. Kirsch M, Vermes E, Radu C, Streich B, Nakashima K, Mekontso-Dessap A et al. Impact of preoperative hemodynamic support on early outcome in patients assisted with paracorporeal Thoratec ventricular assist device. Eur J Cardiothorac Surg 2008;34:262-7.
21. Takayama H, Truby L, Koekort M, Uriel N, Colombo P, Mancini DM et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant 2013;32:106-11.
22. Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T et al. Extracorporeal life support to left ventricular assist device Bridge to heart transplant: a strategy to optimize survival and resource utilization. Circulation 1999;100(19 Suppl):II206-10.
23. Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg 2001;71(3 Suppl):S77-81; discussion S82. -5.
24. Garatti A, Colombo T, Russo C, Lanfranconi M, Milazzo F, Catena E et al. Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump. J Heart Lung Transplant 2005;24:481-5.
25. Aiyagari RM, Rocchini AP, Remenapp RT, Graziano JN. Decompression of the left atrium during extracorporeal membrane oxygenation using a transseptal cannula incorporated into the circuit. Crit Care Med 2006;34: 2603-6.